No abstract available
MeSH terms
-
Antiparkinson Agents / adverse effects
-
Antiparkinson Agents / therapeutic use*
-
Brain / metabolism
-
Brain Stem / pathology
-
Dopamine / biosynthesis*
-
Humans
-
Levodopa / adverse effects
-
Levodopa / metabolism
-
Levodopa / therapeutic use*
-
Male
-
Middle Aged
-
Neurons / metabolism
-
Parkinson Disease / drug therapy*
-
Parkinson Disease / metabolism
-
Parkinson Disease / pathology
-
Practice Guidelines as Topic
Substances
-
Antiparkinson Agents
-
Levodopa
-
Dopamine